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Abstract Yeasts with disruptions in the genes PYC1 and PYC2 
encoding the isoenzymes of pyruvate carboxylase cannot grow in 
a glucose-ammonium edium (Stucka et al. (1991) Mol. Gen. 
Genet. 229, 307-315). We have isolated a dominant mutation, 
BPCI-1, that allows growth in this medium of yeasts with inter- 
rnpted PYC1 and PYC2 genes. The BPCI-1 mutation abolishes 
catabolite repression of a series of genes and allows expression 
of the enzymes of the glyoxylate cycle during growth in glucose. 
A functional glyoxylate cyle is necessary for suppression as a 
dt~rnption of gene ICLI encoding isocitrate lyase abolished the 
pbenotypic effect of BPCI-1 on growth in glucose-ammonium. 
Concurrent expression from constitutive promoters of genes 
I('L1 and MLS1 (encoding malate synthase) also suppressed the 
growth phenotype of pycl pyc2 mutants. The mutation BPCI-1 
is either allelic or closely linked to the mutation DGTI-1. 
K, y words: Pyruvate carboxylase; Glyoxylate cycle; Catabolite 
re!~ression; Yeast 
1. Introduction 
The citric acid cycle performs two important roles: not only 
is it the final oxidation pathway for different ypes of nutrients 
bt~t also several of its intermediates are used for synthesis of 
di Yerent cell constituents [1]. This last function implicates that 
ai,aplerotic reactions hall function to replenish the cycle and 
compensate for the withdrawal of intermediates. When Sac- 
ckaromyces cerevisiae grows in a medium with glucose as car- 
b~ n source and ammonium as nitrogen source the citric acid 
c3 cle is replenished by the action of pyruvate carboxylase (for 
reAews see [2,3]). Hence disruption of the PYC1 and PYC2 
genes, encoding the two isoenzymes of pyruvate carboxylase, 
abolishes growth in the mentioned medium and results in a 
requirement for aspartate for yeasts growing in synthetic media 
w.th glucose as carbon source [4]. Aspartate replenishes the 
cycle by providing oxaloacetate most likely via transamination 
wth  ~-ketoglutarate. We observed that yeast strains with dis- 
rt~ pted P YC1 and P YC2 genes were able to grow in glycerol or 
p~ ruvate with ammonium as nitrogen source without added 
a~partate. This observation indicated that glucose interferes 
w th the operativity of anaplerotic reactions that are functional 
in glycerol or pyruvate growing cells but do not operate during 
gl owth in glucose. In fact, glucose represses i ocitrate lyase and 
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malate synthase, the two specific enzymes of the glyoxylate 
cycle which has an anaplerotic role during growth in 2-C com- 
pounds [5-8]. Therefore, mutations that would allow growth of 
pycl  pyc2 mutants in a glucose-ammonium medium could af- 
fect catabolite repression of genes encoding enzymes that par- 
ticipate in anaplerotic reactions used in the absence of glucose. 
Alternatively, other reactions bypassing pyruvate carboxylase 
could be functional in the new mutants. This article presents 
our results in the search for mutants with the mentioned pheno- 
type. 
2. Material and methods 
2.1. Strains 
All strains used in this work are isogenic and are derived from strain 
W303 IA, MATa ade2 l his3 11,15 1eu2-3,112 ura3 52 trpl-1. The 
strain defective in both pyruvate carboxylase isoenzymes used as start- 
ing material was strain 22B, MA Ta ade2-1 his3-11,15 leu2 ~,  l l 2 ur a3 
trpl 1 pycl :: LEU2 pyc2.': URA3 [4]. Strain 22BHL has the same ge- 
netic background but is pycl ::LEU2 pyc2 :: HIS3 (see below for its 
construction). Crosses were carried out either with W303-1A or with 
W303-1B (MATot ade2 1 his3-11,15 leu2~,l l2 ura3 52 trpl-1). Dip- 
loids were isolated as zygotes. Sporulation and asci dissection were 
performed by conventional methods. 
2.2. Media and growth conditions 
Rich media contained 1% yeast extract, 2% peptone and 2% glucose 
or 2% pyruvate. Minimal media were 0.17% YNB without ammonium 
sulfate (Difco), 40 mM nitrogen source as indicated, 2% glucose or 2% 
pyruvate as carbon and energy sources and the required auxotrophic 
requirements. Growth was at 30°C and liquid cultures were grown with 
shaking. 
2.3. Mutagenes& 
About  10 7 cells of strain 22B were irradiated on a YNB glucose- 
ammonium plate with an UV germicidal lamp. Colonies appearing after 
several days were picked and purified on plates with a medium of the 
same composition. 
2.4. Plasmids 
The following plasmids were used: pUCI8 [9], YEp352 [10], 
YEplacll2 [11], pUC-HIS3 [12] and pGEM-T (Clontech). Plasmid 
pAAH5 carries the promoter and terminator of yeast ADH1 [13]. It was 
digested with HindIII, blunt ended, and NcoI linkers were added to 
generate plasmid pAAH5-NcoI. 
2.5. Gene disruption 
Gene PYC2 was disrupted with HIS3 as follows: The 4.1 kb HindlI- 
Sinai fragment from pRS2 [4] with the gene PYC2 was introduced into 
pUC18 digested with HindllI and SmaI. The resulting plasmid was 
digested with BamHI and the 1.1 kb BamHI-BamHI fragment from 
plasmid pUC-HIS3 was inserted, yielding plC5. For the construction 
of 22BHL, strain 22A (pycl ::LEU2 PYC2) [4] was transformed with 
the 5.2 kb EcoRI-EcoRI fragment of plC5. Gene ICL1 was disrupted 
with HIS3 as follows: plasmid pUC18 was digested with EcoRI and 
BamHI blunt ended and religated. The resulting plasmid was cut with 
XbaI and Sphl and a 2.3 kb XbaI-SphI fragment from plasmid 
pICLI.I-5 [6], carrying the ICL1 gene inserted in it. The resulting 
plasmid was then digested with BamHI and XhoI and a 1.3 kb DNA 
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fragment from plasmid pUC-HIS3 carrying the S. cerevisiae HIS3 gene 
was inserted. The chromosomal ICL1 copy was exchanged with the 
interrupted one as described by Rothstein [12]. Integration was checked 
by Southern blot analysis and lack of enzymatic activity. 
2.6. Construction ofplasmids pADHI-ICL1 and pADH1-MLS1 
Plasmid pADHI-ICL1 carrying the gene ICL1 under the control of 
the promoter of the ADH1 gene was constructed as follows: The coding 
region from ICL1 was amplified with DNA from plasmid pICL1.1-S 
[6] as template using the following oligonucleotides a primers: up- 
stream, 5'-CCCATGGTGCCTATCCCCGTTGG-Y; downstream 5'- 
GGCCATGGCCTATTTCTTTACGCC-3'. Two Ncol sites were 
added to facilitate subcloning (underlined). The1.6 kb NcoI-NcoI frag- 
ment carrying the structural ICL1 gene obtained from PCR was in- 
serted into plasmid pAAH5-NcoI (see above). From this plasmid a 2.3 
kb fusion carrying the ADH1 promoter fused with the ICL1 gene was 
excissed by partial digestion with BamHI and inserted into YEplac112. 
Plasmid pADH1-MLS1 carrying the gene MLS1 under the control 
of the promoter of the ADH1 gene was constructed as follows: The 
coding region of MLS1 was amplified by PCR using DNA from plas- 
mid YE352-MLS (sent by A. Hartig) using the following oligonucleo- 
tides as primers: upstream, 5'-GGTGTCGACACCTATATGACTG- 
3'; downstream 5'-GGGTCGACTGGGGCAAGGGGAGATC-3'. 
Two SalI sites were added to facilitate subcloning (underlined). The 
PCR products were cloned into pGEM-T. Plasmid pAAH5-NcoI was 
digested with NcoI blunt ended, digested with BamHI and the 1.5 kb 
fragment carrying the ADH1 promoter was ligated into YEp352 previ- 
ously cut with Xbal blunt ended and digested with BamHI. The result- 
ing plasmid was digested with Sall and the 1.3 kb SalI-SalI fragment 
carrying the structural gene from MLS1 obtained by PCR was inserted 
in it. This plasmid carries URA3 as yeast marker. 
2. 7. Enzymatic assays 
Enzymatic activities were determined in supernatants of crude ex- 
tracts obtained as described by Blfizquez et al. [14]. Glutamate dehydro- 
genase (NAD) was assayed as in [15], NADH:cytochrome c oxidase 
as in [16], fructose-l,6-bisphosphatase according to Gancedo and 
Gancedo [17], isocitrate lyase after Dixon and Kornberg [18] and ma- 
late dehydrogenase as described by Witt et al. [19]. Protein was assayed 
according to Lowry et al. [20]. 
3. Results 
3.1. Isolation and genetic haracterization of the mutants 
A yeast strain with a disruption in each of the genes P YC1 
and P YC2 encoding pyruvate carboxylase does not grow in a 
PYCI PYC2 
Apycl Apyc2 
Apycl Apyc2 BPCI-i 
Apycl Apyc2 BPCI-I Aicll 
Apycl Apyc2 / pADHI-ICLI 
pADHI-MLSI 
Fig. 1. Growth of strains carrying mutations in both PYC 1 and PYC2 
genes. The yeasts were grown in minimal glucose-ammonium medium 
with the adequate auxotrophic requirements in each case. The relevant 
genotype of the strains is shown at the left. The three spots in each row 
originated from decreasing 1/10 dilutions of the corresponding culture. 
The relevant genotypes and plasmids of each strain are shown on the 
left. 
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Table 1 
Generation times (min) of strains carrying the BPCI-1 mutation, in 
media with different carbon and nitrogen sources 
Relevant genotype Nitrogen source 
Amonium Aspartate 
Glucose Pyruvate Glucose Pyruvate 
PYC1 PYC2 BPC1 150 345 145 230 
pycl pyc2 BPC1 NG 360 145 230 
pycl pyc2 BPCI-1 520 310 260 240 
PYC1 PYC2 BPCI-1 240 335 260 240 
Yeasts were grown in minimal media with 2% glucose or pyruvate as 
carbon sources and the indicated nitrogen sources at a final concentra- 
tion of 40 mM. NG, no growth. 
glucose-ammonium medium but grows in one with glucose and 
aspartate [4] (Fig. 1). After UV irradiation of a pycl :.'LEU2 
pyc2:.'URA3 strain (see section 2) we isolated several 
colonies able to grow in the non-permissive medium. Each of 
these colonies was purified and crossed with an isogenic strain 
also disrupted in both pyruvate carboxylase genes. All diploids 
grew on glucose-ammonium medium indicating that the muta- 
tions were dominant. The segregation of the phenotype of 
growth on minimal medium glucose was 2 + : 2- in all complete 
tetrads analyzed for each mutant indicating that the mutations 
were nuclear and monogenic. We provisionally named them 
BPC for bypass of pyruvate carboxylase. Adequate crosses 
among independent mutants howed that they belonged to two 
complementation groups BPC1- and BPC2 We have studied 
and further characterized the mutation BPCI-1. 
The mutation BPCI-I was taken out of the pycl::LEU2 
pyc2:.'URA3 background after dissection of 53 com- 
plete tetrads derived from a cross between the mutant and a 
wild type. It can be calculated that with a probability of 1/36 
a tetrad with two spores pycl.'.'LEU2 BPC1, pyc2:.'URA3 
BPC1 and two PYCI PYC2 BPCI-1 will be found. We identi- 
fied a tetrad with these characteristics and a P YC1 P YC2 
BPCI-1 spore was selected and used in this work. Its pheno- 
typic behaviour (see below) showed that it had the expected 
genotype. 
3.2. Generation times 
The generation times on different culture media of strains 
carrying the pycl :: LEU2 pyc2 :: HIS3 interruptions, the dou- 
ble interruption and the BPCI-1 mutation or the BPCI-1 mu- 
tation alone are shown in Table 1. As expected, the pycl pyc2 
disruptant does not grow in minimal glucose-ammonium me- 
dium. A strain bearing the BPCI-1 mutation grew in this me- 
dium although its generation time was over 8 h as compared 
with 2 h 30 min for the wild type. The BPCI-1 mutation by itself 
decreased the growth rate in glucose media but had no effect 
in media with pyruvate as carbon source. 
3.3. Biochemical characterization of the mutants 
We assayed several enzymes repressed by glucose and related 
with the replenishment of the citric acid cycle like isocitrate 
lyase, malate dehydrogenase and glutamate dehydrogenase, 
and others not directly related with this function. These activi- 
ties were assayed uring growth in glucose or pyruvate contain- 
ing media in strains carrying the double P YC1 P YC2 interrup- 
tion, the double interruption and the BPCI-1 mutation or the 
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BPCI-1 mutation alone. The results of the assays are shown in 
Table 2. It can be seen that in the BPCI-I mutants all enzymes 
tested had lost the repression by glucose although to different 
extents. The strongest effect was observed with cytochrome c 
oxidase which was totally derepressed. Malate dehydrogenase 
anti glutamate dehydrogensae w re derepressed to intermediate 
levels while isocitrate lyase and fructose-l,6-bisphosphatase 
reached values of 17 and 25%, respectively, of the levels meas- 
urLd in pyruvate grown cells. It appears therefore that a defect 
in he BPC1 gene affects the correct functioning of catabolite 
rel ression of a variety of genes. 
3., Suppression of the pyruvate carboxylase-less phenotype 
requires function of the glyoxylate cycle 
['he BPCI-1 mutation could suppress the pyruvate carbox- 
yl~se-less phenotype ither by relieving the repression of the 
glx oxylate cycle enzymes or by allowing the operation of some 
re~,ction that would bypass pyruvate carboxylase function. If 
tht first idea is correct, disruption of one of the genes encoding 
a s 9ecific enzyme of the cycle would abolish the effect of BPC1- 
1. I'herefore, we disrupted the gene ICL1 encoding isocitrate 
ly~ se in a wild type and in a strain with the relevant genotype 
p) '1 .': LEU2 pyc2 :: URA3 BPCI-1. While disruption of ICL1 
in the wild type was without effect on growth in glucose (not 
shown) it abolished growth in glucose-ammonium in the strain 
ca rying the BPCI-1 suppressor (Fig. 1). Growth in glucose- 
asi~artate of this strain was unaffected by the ICLI disruption 
(n ~t shown). This result shows that functionality ofthe glyoxyl- 
at, cycle is necessary for the suppression effected by BPCI-1. 
Tt test if functionality of the cycle would be sufficient to com- 
pe 1sate for the defect caused by the double pycl pyc2 mutation 
wt constructed plasmids with the genes ICLI and MLS1, en- 
ce ling isocitrate lyase and malate synthase, respectively, under 
th : control of the ADHI promoter. These plasmids expressed 
is, citrate lyase and malate synthase when the yeasts grew in 
gl lcose to 75 and 50%, respectively, of the levels found in fully 
de,'epressed cultures. When these plasmids were introduced in 
a ;train carrying disrupted PYC1 PYC2 genes the transfor- 
mmts carrying these constructs were able to grow in glucose- 
ar Lmonium (Fig. l) although growth was slower than that of 
th )se carrying the BPCI-1 mutation. 
3. :. The mutation BPCI-1 is allelic or closely linked with 
DGTI- 1 
While this work was in progress another dominant mutation, 
D,TTI-1, showing asimilar effect on the derepression f glucose 
re ~ressed enzymes, was isolated in our laboratory by a different 
al proach [24]. When this mutation was introduced in a py- 
ru cate carboxylase-less strain we found that it suppressed the 
growth phenotype. We therefore tested the possible allelism of 
DGTI-1 and BPCI-1. The progeny of a cross between strains 
of genotypes pycl : : LEU2 pyc2 :: URA3 BPCI-1 and 
pycl :: LEU2 pyc2:: URA3 DGTI-1 was analyzed. Eight com- 
plete tetrads gave a 4 ÷:0- segregation for growth in glucose- 
ammonium. This result indicates that BPCI-1 and DGTI-1 are 
either allelic or closely linked. 
4. Discussion 
We have isolated a dominant mutation, BPCI-I, that allows 
yeasts with both PYCI and PYC2 genes interrupted to grow 
in glucose-ammonium media. The molecular basis of the sup- 
pression appears to be the release from carbon catabolite re- 
pression of the genes encoding the enzymes of the glyoxylate 
cycle. That the glyoxylate cycle plays a predominant role in the 
suppression of the pyruvate carboxylase-deficient phenotype is 
highlighted by two results: (a) the inability of the BPCI-I mu- 
tation to suppress the pyruvate carboxylase-deficient pheno- 
type when the gene ICL1 is disrupted and (b) the ability of the 
pyruvate carboxylase-deficient mutants to grow in glucose-am- 
monium medium when both ICLI and MLS1 are expressed 
from the non-repressible ADHI promoter. The fact that these 
last cells grew somewhat slower in glucose-ammonium than 
those carrying the BPCI-1 mutation may be due to the fact that 
in the BPCI-1 cells respiratory enzymes - and likely other 
tricarboxylic acid cycle enzymes were derepressed and the 
glucose could be used more effectively for energy production. 
Although it has been reported that interruption of PYC1 
results in an aspartate requiring phenotype during growth in 
ethanol [21], we have consistently found that in our strain each 
gene could substitute for the other for growth in the carbon 
sources we tested and that the requirement for aspartate was 
only observed uring growth in repressing carbon sources. Dif- 
ferent genetic backgrounds that influence the expression of 
each of the genes may account for this difference in results. 
The dominant character of the mutation BPCI-1 suggests 
that the product of the wild type gene could be a repressor 
acting on several systems controlled by glucose. Some of the 
properties of the mutant described were reminiscent of those 
reported for the mutations CCR80 [22] or CCR91 [23]. Unfor- 
tunately, these mutants were not available so that it was not 
possible to test their possible allelism with the mutation re- 
ported here. However, we found that the mutation described 
was allelic or very closely linked with the mutation DGTI-1 
reported by Gamo et al. [24]. This mutation, isolated as a 
suppressor of the toxic effect caused by glucose in a 
phosphoglycerate mutase mutant, presents a decreased glucose 
transport and releases from catabolite repression a series of 
Ttble 2 
SFecific activities (mU/mg protein) of several enzymes repressed by glucose in strains carrying the BPCI-1 mutation 
R~ levant genotype ICL MDH GIuDH CytcOx FbPase 
G P G P G P G P G P 
P 7C1 PYC2 BPC1 < 1 49 159 2670 10 203 15 100 < 1 65 
p) "1 pye2 BPC1 1 81 190 2350 17 265 20 78 1 60 
P3 ~1 pyc2 BPCI-1 17 79 586 2840 126 185 110 108 13 58 
P~.'C1 PYC2 BPCI-1 7 41 380 2100 100 190 100 107 15 60 
YLasts were grown in rich medium with 2% glucose (G) or pyruvate (P) as carbon source and harvested during the exponential phase of growth. 
Erzymes were assayed as described in section 2. Figures are mean values of at least hree different cultures. ICL, isocitrate lyase: MDH, malate 
dchydrogenase; GluDH, glutamate dehydrogenase (NAD); CytcOx, cytochrome c oxidase; FbPase, fructose-l,6-bisphosphatase. 
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enzymes. The results presented show that carbon catabolite 
repression may in some cases affect the growth behaviour of 
yeasts in different nitrogen sources and also demonstrate the 
potentiality to find new types of carbon catabolite repression 
mutations of searching for suppressors of other mutations. 
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